COVID-19 Pandemic as an Excellent Opportunity for Global Health Diplomacy

Taghizade, Sanaz; Chattu, Vijay Kumar; Jaafaripooyan, Ebrahim; Kevany, Sebastian

doi:10.3389/fpubh.2021.655021

Cited by 23 publications

(24 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…COVAX is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Vaccine Alliance, and WHO, with UNICEF as a key delivery partner and PAHO as the procurement agent in the Americas. This facility aims to ensure fairer global vaccine distribution [50] and address the prevailing inequities [51] , but the end result can only be assessed after some time based on fulfilling its commitments to the nations [52] .…”

Section: Discussionmentioning

confidence: 99%

COVID-19 pandemic containment in the Caribbean Region: A review of case-management and public health strategies

Umakanthan¹,

Chauhan²,

Gupta³

et al. 2021

AIMSPH

Self Cite

View full text Add to dashboard Cite

<abstract> <p>COVID-19 emerged initially from Wuhan, Hubei province, China, in late December 2019, and since then, it has spread globally to be declared a pandemic by the World Health Organization. The Caribbean region started reporting COVID-19 cases in early March 2020, triggering new regional public health crises. The initial suspects and confirmed cases across the Caribbean countries were mainly imported cases and from cruise ships. The clinical manifestations varied from fever, cough, and malaise in mild cases to acute respiratory distress syndrome (ARDS) and shock in severe cases. The Caribbean Public Health Agency has provided frequent updates on the preventive strategies and quarantine measures across the Caribbean member states. COVID-19 has had a serious impact on the Caribbean region's health system, economy, and psychology. This review presents the Caribbean perspective of COVID-19, detailing the epidemiology, clinical manifestations, diagnosis, management, and preventive and surveillance measures. Vaccine hesitancy was found to be a major challenge that needs appropriate health education strategies to address the public. Strong leadership and regional collaboration among the Caribbean member states are necessary to provide optimal real-time data to the public and implement appropriate and effective guidelines in the island states.</p> </abstract>

show abstract

Section: Discussionmentioning

confidence: 99%

COVID-19 pandemic containment in the Caribbean Region: A review of case-management and public health strategies

Umakanthan¹,

Chauhan²,

Gupta³

et al. 2021

AIMSPH

Self Cite

View full text Add to dashboard Cite

show abstract

“… 39 A recent article by Taghizade et al have summarized the emerging scope of GHD in this post-pandemic world by influencing the five global arenas, namely (1) international cooperation and global solidarity, (2) Global Economy, Trade and Development, (3) Global Health Security, (4) Strengthening health systems and (5) Addressing inequities to achieve the global health targets. 41 …”

Section: Introductionmentioning

confidence: 99%

Prioritizing ‘equity’ in COVID-19 vaccine distribution through Global Health Diplomacy

Singh

Chattu

2021

Health Promot Perspect

Self Cite

View full text Add to dashboard Cite

With over 4 million deaths worldwide, the current coronavirus disease 2019 (COVID-19)pandemic is regarded as one of the worst pandemics in history. With its wider devastating consequences, even so-called affluent countries could not provide full coverage for COVID-19vaccines and medications to all of their citizens. Against this backdrop, the main aim of this article is to examine how Global Health Diplomacy (GHD) can play a role in prioritizing vaccine equity in the global health agenda in the fight against COVID-19. The majority of developed countries’ healthcare systems have been exposed and have reached a tipping point.After the completion of eighteen months of the pandemic, only five countries were able to produce vaccines for the treatment of COVID-19. This pandemic has divided the world into two blocs: those with vaccines, such as the United States, the United Kingdom, Russia, China, and India; and those without, such as the rest of the world. The greatest challenges are vaccine inequalities, inequities and distribution, which undermine the global economic recovery. Many poor countries are still waiting for the initial doses to be delivered to their citizens, while some rich nations are planning for booster doses. GHD plays a critical role in establishing successful global collaborations, funding mechanisms and ensuring international cooperation through the combined efforts of all stakeholders. Besides, global solidarity is necessary to lessen the wider gaps between the vaccination status of rich and poor nations. Therefore, through GHD, the vaccine gaps and inequities can be addressed to strengthen global health security and accelerate global economic recovery.

show abstract

“…The recent proposal to waive off certain provisions of the TRIPS for the prevention, containment, and treatment of COVID-19 by India and South Africa at the WTO presents an important opportunity for all African governments to unite and stand up for public health, global solidarity, and equitable access and a functional AMA would serve a great purpose for similar challenges in the future [69]. As highlighted by Taghizade et al, GHD proves to be very useful for negotiating better policies, stronger partnerships and achieving international cooperation in this phase with many geopolitical shifts and nationalist mindset among many nations at this stage of COVID-19 vaccine roll-out [70]. Moreover, Binagwaho et al have highlighted that the pharmaceutical companies should share their technologies to increase the supply and reduce the prices; the governments should prioritize equitable distribution to the most at-risk in LMICs and should bolster their logistical capacity in preparation for mass vaccination campaigns [71].…”

Section: Future Of Africa With African Medicines Agency In Actionmentioning

confidence: 99%

Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review

Chattu

Dave²,

Reddy

et al. 2021

IJERPH

Self Cite

View full text Add to dashboard Cite

The African continent is home to 15% of the world’s population and suffers from a disease burden of more than 25% globally. In this COVID-19 era, the high burden and mortality are further worsened due to inequities, inequalities such as inadequate health systems, scarce financial and human resources, as well as unavailability of inexpensive medicines of good quality, safety, and efficacy. The Universal Health Coverage ensures that people have access to high-quality essential health services, secure, reliable, and affordable essential medicines and vaccines, as well as financial security. This paper aimed at addressing the critical need for a continental African Medicines Agency (AMA) in addressing the inequities and the role of global health diplomacy in building consensus to support the ratification of the Treaty of AMA. A literature review was done in Scopus, Web of Science, MEDLINE/PubMed, and Google Scholar search engine to identify the critical literature in the context of study objectives. All the articles published after 2015 till 2021 in the context of AMA were included. African Health Strategy 2016–2030 highlighted the importance of an African regulatory mechanism for medicines and medical products. Through global health diplomacy (GHD), the African Union and its partners can negotiate and cooperate in providing infrastructural, administrative, and regulatory support for establishing the AMA. The paper emphasizes the South–South cooperation and highlights the contributions of India and China in the supply of medicines and vaccines to Africa. A strong AMA created through GHD can be a vital instrument in utilizing Trade-Related Aspects of Intellectual Property Rights (TRIPS) flexibilities extension and an ideal partner for European and other regional regulatory authorities seeking to stem the tide of counterfeit, sub-standard, or fake products.

show abstract

COVID-19 Pandemic as an Excellent Opportunity for Global Health Diplomacy

Cited by 23 publications

References 32 publications

COVID-19 pandemic containment in the Caribbean Region: A review of case-management and public health strategies

COVID-19 pandemic containment in the Caribbean Region: A review of case-management and public health strategies

Prioritizing ‘equity’ in COVID-19 vaccine distribution through Global Health Diplomacy

Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review

Contact Info

Product

Resources

About